Filter posts

Is Regulatory Transformation for Alzheimer’s Therapies Needed?

BIO 2014’s  session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move …

Exchange Plans are Helping Patients, But Challenges Remain

After describing many of the benefits the Exchanges have brought to patients—including access to both …

Access to Big Data

Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James …

Seeing is Believing

PET and MRI imaging helps companies to make go/no go decisions earlier Attrition or failure …

A Better Way to Make Unnatural Amino Acids Discovered by Yu

Certain amino acids that are not found in nature are highly sought after by pharmaceutical …

New Target for Alzheimer’s Disease

Biotechnologists have developed a drug candidate that blocks production of diseasecausing neurotoxins in mouse models Reducing …

Making the Case for Personalized Medicine

Personalized medicine is the customization of healthcare. Already, a suite of molecular approaches is being …

21st Century Cures: Accelerating the Discovery-Development-Delivery Cycle

How can we give patients faster access to innovative treatments and cures? That’s the question …

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading …

Digital Health in a Mobile World

Healthcare is shaping up to be an important area for all the big technology companies …